Literature DB >> 17386981

Prescription opioid abuse among enrollees into methadone maintenance treatment.

Andrew Rosenblum1, Mark Parrino, Sidney H Schnoll, Chunki Fong, Carleen Maxwell, Charles M Cleland, Stephen Magura, J David Haddox.   

Abstract

A multi-state survey of 5663 opioid dependent persons enrolling in 72 methadone maintenance treatment programs (MMTPs) was conducted to determine the prevalence of prescription opioid (PO) abuse, factors associated with PO abuse and sources for POs. Regions where PO abuse was believed to be prevalent were oversampled; primary opioid was defined as the drug used the most before coming to the MMTP. Among primary heroin abusers, 69% reported abusing POs. Opioid abuse frequencies among primary PO abusers were oxycodone (79%), hydrocodone (67%), methadone (40%), morphine (29%), heroin (13%), hydromorphone (16%), fentanyl (9%) and buprenorphine (1%). Correlates (p < or = .01) of PO abuse, using general estimating equations, were: low urbanicity (MMTPs located in comparatively low population density counties), white ethnicity, no history of injecting primary drug, no previous methadone treatment, younger age, chronic pain, and pain as a reason for enrollment. The most frequent sources of POs were dealer, friend or relative, and doctor's prescription; least frequent were Internet and forged prescription. One-third of PO abusers reported a history of injecting their primary drug. PO abuse is highly prevalent among MMTP patients. Future studies should describe HIV/HCV needle injection practices, characteristics that predict treatment outcomes, and factors that contribute to higher prevalence of persistent pain among PO abusers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386981     DOI: 10.1016/j.drugalcdep.2007.02.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  106 in total

1.  Patterns of prescription medication diversion among drug dealers.

Authors:  Khary K Rigg; Steven P Kurtz; Hilary L Surratt
Journal:  Drugs (Abingdon Engl)       Date:  2012

2.  Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse.

Authors:  John S Brownstein; Traci C Green; Theresa A Cassidy; Stephen F Butler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

3.  Prescription Drug Abuse & Diversion: Role of the Pain Clinic.

Authors:  Khary K Rigg; Samantha J March; James A Inciardi
Journal:  J Drug Issues       Date:  2010

4.  Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

5.  Prescribers' expectations and barriers to electronic prescribing of controlled substances.

Authors:  Cindy Parks Thomas; Meelee Kim; Ann McDonald; Peter Kreiner; Stephen J Kelleher; Michael B Blackman; Peter N Kaufman; Grant M Carrow
Journal:  J Am Med Inform Assoc       Date:  2011-09-21       Impact factor: 4.497

6.  Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Daniel Alford; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2010-08-19

7.  "It Ruined My Life": The effects of the War on Drugs on people who inject drugs (PWID) in rural Puerto Rico.

Authors:  R Abadie; C Gelpi-Acosta; C Davila; A Rivera; M Welch-Lazoritz; K Dombrowski
Journal:  Int J Drug Policy       Date:  2017-07-14

8.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

9.  Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers.

Authors:  Andrew C Meyer; Mollie E Miller; Stacey C Sigmon
Journal:  Addict Behav       Date:  2014-11-18       Impact factor: 3.913

10.  Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.

Authors:  Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-05-08       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.